NUE up +0.73% percent Today $NUE High is at 53.81 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 13, 2014 at 3:14 PM

NUE up +0.73% percent Today $NUE High is at 53.81 and the Low 53.35 with current volume of 143,917.

Recent News posted below.

Nucor Corp NUE other info.
http://investorshangout.com/Nucor-Corp-NUE-52120/

NUE Nucor Corp Recent Headline News

AK Steel (AKS) Reaches New Labor Agreement with USW - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 6:09PM CST
AK Steel (AKS) has announced the ratification of a new three-year labor agreement by the members of USW Local 1915.
STLD: 22.32 (-0.09), NUE: 53.30 (+0.03), AKS: 6.35 (+0.11), X: 35.18 (+0.40)

Mechel Posts Operational Data, Fails to Meet Listing Norms - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 5:48PM CST
Mechel (MTL) releases its third-quarter operational results and receives notice from NYSE regarding defiance of ADR norms.
NUE: 53.30 (+0.03), MTL: 0.84 (-0.04), X: 35.18 (+0.40)

Nucor (NUE) Suspends Production at Louisiana Plant - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 4:50PM CST
Nucor Corporation (NUE) announced that an equipment failure has occurred at Nucor Steel Louisiana in St. James Parish. It is associated with a major failure experienced by the process gas heater on Nov 2.
NUE: 53.30 (+0.03), MTL: 0.84 (-0.04), X: 35.18 (+0.40)

Judge to hear case to block silicon metal plant
By JEFF AMY - AP - Tue Nov 11, 4:01PM CST
JACKSON, Miss. (AP) — A federal judge has given opponents of a silicon metal plant in Mississippi's northeast corner a chance to make their case in court.
NUE: 53.30 (+0.03)

Equipment Failure At Nucor Steel Louisiana
PR Newswire - Mon Nov 10, 2:51PM CST
Nucor Corporation (NYSE: NUE) announced that an equipment failure occurred at Nucor Steel Louisiana in St. James Parish. The failure is related to the process gas heater, which experienced a major failure on November 2, 2014. There were no injuries, no environmental impact and no damage to any other part of the direct reduced iron (DRI) facility as a result of this incident. Production operations were suspended after the failure. Nucor is still assessing the extent of the equipment damage and cannot estimate the length of time needed to make the necessary repairs to the process gas heater at this time. Nucor will provide an estimate of when the facility will be fully operational when it is available.
NUE: 53.30 (+0.03)

AK Steel (AKS) Up on Winning NOES Trade Cases - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 2:04PM CST
AK Steel's (AKS) shares climbed after the ITC reached a positive decision that imposed antidumping orders on six nations.
STLD: 22.32 (-0.09), NUE: 53.30 (+0.03), AKS: 6.35 (+0.11), X: 35.18 (+0.40)

ArcelorMittal (MT) Swings to Profit in Q3, Shipments Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 11:50AM CST
Steel giant ArcelorMittal (MT) reported net income of $22 million or a penny per share in the third quarter of 2014, contrary to a loss of $193 million or 12 cents per share in the year ago quarter.
GGB: 4.23 (-0.13), NUE: 53.30 (+0.03), X: 35.18 (+0.40), MT: 12.01 (-0.02)

Nucor Steel: High Expectations For Growth
Kerry Prazak, CFP - at Seeking Alpha - Fri Nov 07, 1:26AM CST

NUE: 53.30 (+0.03)

Steel Is Real: Nucor Is A Great Value Buy
Daniel Jennings - at Seeking Alpha - Thu Nov 06, 5:59AM CST

F: 14.86 (+0.28), NUE: 53.30 (+0.03)

'Mad Money' Lightning Round: Pull the Trigger on Baxter
at The Street - Thu Nov 06, 5:00AM CST
Cramer likes Illumina but isn't a big fan of GEO Group or AK Steel Holdings.
RIG: 26.10 (-0.98), GEO: 39.89 (-0.10), TMO: 118.23 (-0.28), ESV: 38.27 (-1.00), NUE: 53.30 (+0.03), BAX: 72.11 (+0.78), ILMN: 184.94 (-1.98), AKS: 6.35 (+0.11), OXY: 85.65 (-2.94)

Cramer's Lightning Round - Baxter May Go Faster (11/5/14)
SA Editor Miriam Metzinger - Seeking Alpha - Thu Nov 06, 4:59AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday November 5. Bullish Calls: Baxter (NYSE: BAX ): "I think it is finally starting to run. It has lagged, but it is time to pull the...
RIG: 26.10 (-0.98), GEO: 39.89 (-0.10), TMO: 118.23 (-0.28), NUE: 53.30 (+0.03), BAX: 72.11 (+0.78), ILMN: 184.94 (-1.98), AKS: 6.35 (+0.11), OXY: 85.65 (-2.94)

Jim Cramer's 'Mad Money' Recap: What a Republican Senate Means for Stocks
at The Street - Wed Nov 05, 7:20PM CST
It's bullish news but you can't buy just anything, Cramer says.
ACT: 241.91 (+1.29), LMT: 187.90 (+1.03), XOM: 94.27 (-1.11), ILMN: 184.94 (-1.98), AKS: 6.35 (+0.11), KORS: 70.86 (-0.14), PAYX: 47.41 (-0.08), RIG: 26.10 (-0.98), EOG: 94.83 (-2.73), COST: 138.38 (+1.48), TWTR: 40.59 (-1.95), OXY: 85.65 (-2.94), KO: 42.76 (+0.05), SEAS: 16.99 (+0.14), TMO: 118.23 (-0.28), NUE: 53.30 (+0.03), TRIP: 68.50 (-1.88), DISCA: 32.77 (+0.91), CHUY: 22.25 (-0.24), LB: 76.90 (-1.04), GEO: 39.89 (-0.10), ESV: 38.27 (-1.00), MPC: 92.92 (-2.09), BAX: 72.11 (+0.78), MRK: 59.36 (+0.05), EXPE: 86.20 (-0.91), STI: 39.85 (unch)

L.B. Foster (FSTR) Misses Q3 Earnings on Expense Worries - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 11:10AM CST
L.B. Foster Company (FSTR) posted adjusted earnings of 88 cents per share for third-quarter 2014, down 7.4% from 95 cents earned in the year-ago quarter.
STLD: 22.32 (-0.09), FSTR: 51.94 (-1.56), NUE: 53.30 (+0.03), MTL: 0.84 (-0.04)

AK Steel's Q3 Earnings Top, Shares Sag on Outage Concern - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:50AM CST
AK Steel (AKS) saw its losses narrow in the third quarter and its results topped expectations.
STLD: 22.31 (-0.10), NUE: 53.30 (+0.03), AKS: 6.35 (+0.11), X: 35.19 (+0.41)

Steel Stocks Fall On AK Steel Warning, Price Concerns
at Investor's Business Daily - Tue Nov 04, 3:05PM CST
Steelmaker stocks tumbled Tuesday amid a confluence of factors, such as growing price worries, a warning by AK Steel (AKS) that Q4 results will be hit by a planned outage, and bearish comments by hedge fund manager David Einhorn on U.S. Steel's (X)...
STLD: 22.31 (-0.10), NUE: 53.30 (+0.03), AKS: 6.35 (+0.11), X: 35.19 (+0.41), MT: 12.01 (-0.02)

LB Foster Shares Up on Acquisition, 33% Dividend Hike - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 3:34PM CST
LB Foster Co. (FSTR), the premium railroad, tubular and construction product manufacturing firm has increased its quarterly dividend by 33% to 4 cents per share on Oct 31, 2014.
STLD: 22.31 (-0.10), FSTR: 51.94 (-1.56), NUE: 53.30 (+0.03), MTL: 0.84 (-0.04)

Vale (VALE) Misses Q3 Earnings Estimates, Shares Dip - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 10:50AM CST
Mining giant Vale S.A. (VALE) reported weak financial results for third-quarter 2014 on Oct 27, following which the share price of the company declined 4.6%.
AA: 16.71 (-0.17), NUE: 53.30 (+0.03), VALE: 8.74 (-0.08), GPRE: 32.90 (-0.71)

How Did These 20 Historically Strong October Stocks Hold Up?
at The Street - Mon Nov 03, 9:58AM CST
Historically, October is not the best month for stocks. This month's market volatility put the top 20 stocks in October to the test. Click through to see how they fared.
STT: 76.35 (-1.10), NUE: 53.30 (+0.03), DAL: 44.09 (+0.69), ICE: 223.10 (+1.90), MHFI: 90.55 (+0.04), ORCL: 40.62 (+0.48), ADBE: 71.70 (+0.29), MS: 35.73 (-0.24), ACE: 110.70 (-0.07), BTU: 10.98 (-0.62), GS: 189.94 (-0.24), R: 90.63 (-1.69), EXPD: 43.78 (-0.13), GOOGL: 555.07 (-3.18), SWN: 33.25 (-1.16), NDAQ: 43.72 (-0.31), AAPL: 112.79 (+1.54), MA: 84.00 (-0.35), TRV: 103.20 (+0.14)

Cliffs, Nucor in talks over stake in Bloom Lake iron ore mine
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 1:15PM CDT

NUE: 53.30 (+0.03), CLF: 10.43 (-0.28)

United States Steel (X) Jumps: Stock Adds 5.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 8:04AM CDT
United States Steel Corp. (X) was a big mover last session, as the company saw its shares rise over 5% on the day.
FSTR: 51.94 (-1.56), NUE: 53.30 (+0.03), MTL: 0.84 (-0.04), X: 35.19 (+0.41)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...